Adverse Events Associated with Apremilast and Deucravacitinib for Psoriasis: A Pharmacovigilance Study Based on the FAERS Database

Yuanyuan Xu,1,2,* Xinjin Liu,1,2,* Linghong Guo,1,2 Xian Jiang1,2 1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 2Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Xu Y, Liu X, Guo L, Jiang X
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Dove Medical Press 2025-05-01
Cyfres:	Clinical, Cosmetic and Investigational Dermatology
Pynciau:	apremilast deucravacitinib pharmacovigilance analysis safety signals adverse events psoriasis
Mynediad Ar-lein:	https://www.dovepress.com/adverse-events-associated-with-apremilast-and-deucravacitinib-for-psor-peer-reviewed-fulltext-article-CCID
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!